These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25820336)

  • 1. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic preconditioning: short-term tricks for long-term gain.
    Deb A; Wang Y
    Circulation; 2015 Apr; 131(17):1468-70. PubMed ID: 25820337
    [No Abstract]   [Full Text] [Related]  

  • 3. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice.
    Yuan YP; Shen ZY; Teng T; Xu SC; Kong CY; Zeng XF; A Hofmann Bowman M; Yan L
    J Am Heart Assoc; 2024 May; 13(10):e028006. PubMed ID: 38726894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
    Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
    Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.
    Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J
    Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
    Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
    Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and transient sodium-hydrogen exchanger isoform 1 inhibition attenuates subsequent cardiac hypertrophy and heart failure following coronary artery ligation.
    Kilić A; Huang CX; Rajapurohitam V; Madwed JB; Karmazyn M
    J Pharmacol Exp Ther; 2014 Dec; 351(3):492-9. PubMed ID: 25216745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
    Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
    Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a.
    Xie J; Zheng C; Shen M; Lu W; Li M; He M; Chen L; Ma S; Zhu Y; Lin H; Xiu J; Liao W; Bin J; Liao Y
    Cell Mol Life Sci; 2023 Aug; 80(9):267. PubMed ID: 37626241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic preconditioning attenuates myocardial ischemia/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2.
    Ma L; Shi H; Li Y; Gao W; Guo J; Zhu J; Dong Z; Sun A; Zou Y; Ge J
    Sci Bull (Beijing); 2021 Oct; 66(20):2099-2114. PubMed ID: 36654268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound biomicroscopy validation of a murine model of cardiac hypertrophic preconditioning: comparison with a hemodynamic assessment.
    Huang J; Wu J; Wang S; You J; Ye Y; Ding Z; Yang F; Wang X; Guo J; Ma L; Yuan J; Shen Y; Yang X; Sun A; Jiang H; Bu L; Backx PH; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H138-H148. PubMed ID: 28455286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.